BERLIN, June 21 /PRNewswire-FirstCall/ — Medco
Health Solutions, Inc. (NYSE: MHS) and Celesio AG, two of the world’s leading
pharmacy-driven healthcare companies, today announced a joint
venture with a long-term goal of improving patient health and
helping to relieve the crushing financial burden on healthcare
payors across Europe.
(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO
)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100609/MEDCOLOGO
)
Headquartered in Amsterdam, the
50/50 joint venture, Medco Celesio B.V., combines Medco and
Celesio’s strengths in pharmacy-driven clinical care. Medco
Celesio B.V. will target patients with chronic or complex
conditions, such as diabetes, asthma, high-cholesterol and heart
disease. It will concentrate on innovative, integrated
clinical services designed to improve patient adherence, integrate
care across multiple providers, enhance safety and deliver greater
value across the healthcare system.
“Our portfolio of proven clinical solutions can be customized to
address the growing demand for affordable, high-quality care that
is relevant across geogra
‘/>”/>
SOURCE